Interpace Biosciences Inc (IDXG) financials · P/E 1.8, rev $18.2M
Interpace Biosciences Inc (IDXG) P/E 1.8, rev $18.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $38.7M | $46.9M |
| Cost of Revenue | $14.6M | $17.0M |
| Gross Profit | $24.1M | $29.9M |
| Operating Income | $4.1M | $8.1M |
| Net Income | $24.6M | $6.7M |
| EPS (Diluted) | $0.89 | $0.40 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $33.8M | $14.8M |
| Current Assets | $9.9M | $11.8M |
| Cash & Equivalents | $2.5M | $1.5M |
| Inventory | $1.1M | $1.2M |
| PP&E | $1.4M | $1.4M |
| Total Liabilities | $11.5M | $17.0M |
| Current Liabilities | $5.1M | $10.6M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $22.4M | -$2.2M |
| Retained Earnings | -$210.8M | -$235.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $5.8M | $4.6M |
| CapEx | $356.0K | $876.0K |
| Investing Cash Flow | -$356.0K | -$876.0K |
| Financing Cash Flow | -$4.4M | -$5.8M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $1.0M | -$2.0M |
| Free Cash Flow | $5.5M | $3.8M |
FAQ
What is IDXG P/E and revenue?
Interpace Biosciences Inc (IDXG) P/E 1.8, rev $18.2M.
What is IDXG revenue?
Interpace Biosciences Inc last cached revenue is $38.7M (FY2025).
Is IDXG profitable?
Interpace Biosciences Inc last cached net income is $24.6M.
What are IDXG total assets?
Interpace Biosciences Inc last cached total assets are $33.8M.
What is IDXG free cash flow?
Interpace Biosciences Inc last cached free cash flow is $5.5M.
Not investment advice. Cached statements, not a live tape.